Systematic Review of the pCR Rate of Apatinib Combined With Albumin Paclitaxel and Carboplatin Regimen for Neoadjuvant Therapy of Triple-negative Breast Cancer
| Drug | Drug Name | Drug Description |
|---|
| Drug | Drug Name | Target | Type |
|---|
| Drug | Drug Name | Phase | Status | Count |
|---|---|---|---|---|
| DB00062 | Albumin human | 2 | Unknown Status | 1 |
| DB00958 | Carboplatin | 2 | Unknown Status | 1 |
| DB01229 | Paclitaxel | 2 | Unknown Status | 1 |
| DB14765 | Rivoceranib | 2 | Unknown Status | 1 |